Resource Library

A vaccine trial can enroll on schedule and still miss the disease window or lose endpoint events to incomplete reporting, delayed testing or unusable specimens. For sponsors whose next development decision depends on an interpretable result, predictability must be designed into the study from the start.

Building Predictable Vaccine Trials: Five Drivers to Protect Endpoints offers a practical framework for planning around these risks. Download the playbook to explore how to:

• Choose countries and sites with both endpoint opportunity and the ability to execute
• Align activation, enrollment and surveillance with the disease window
• Protect endpoint data through participant follow-up, testing and specimen management
• Define the signals that should prompt review and action
• Prepare feasible responses before conditions change

Drawing on Syneos Health’s PredictaVax™ approach, the playbook gives vaccine development leaders questions to ask while plans can still be adjusted.

Download the playbook to strengthen the decisions behind your next vaccine study.